Bender Robert & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,578
Closed -$523K 61
2024
Q2
$523K Buy
+3,578
New +$532K 0.11% 34

Other funds holding JNJ

Bender Robert & Associates's JNJ Position: Q1 2026 in Review

Bender Robert & Associates reduced its Johnson & Johnson (JNJ) stake by 3.6% in Q1 2026, selling an estimated $28K and leaving 3,224 shares worth $788K. The position accounts for 0.19% of the portfolio, ranked #27.

Bender Robert & Associates first reported a position in JNJ in Q2 2013 and has held it in 51 quarters since. The position peaked at $971K in Q4 2022. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Bender Robert & Associates held 3,224 shares of Johnson & Johnson worth $788K as of Q1 2026.
  • Bender Robert & Associates sold 120 Johnson & Johnson shares in Q1 2026, an estimated $28K.
  • Johnson & Johnson made up 0.19% of Bender Robert & Associates's portfolio in Q1 2026, its #27 holding.
  • Bender Robert & Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 51 quarters since.
  • Bender Robert & Associates's Johnson & Johnson position peaked at $971K in Q4 2022.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Bender Robert & Associates's 13F filing for Q1 2026, filed 23 Apr 2026.